These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1097 related items for PubMed ID: 23967739

  • 41. [An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma].
    Liu WP, Zheng W, Wang XP, Song YQ, Xie Y, Tu MF, Lin NJ, Ping LY, Ying ZT, Deng LJ, Zhang C, Zhu J.
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):521-4. PubMed ID: 22338173
    [Abstract] [Full Text] [Related]

  • 42. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
    Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A.
    Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713
    [Abstract] [Full Text] [Related]

  • 43. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil.
    Silva CM, Costi C, Costa C, Michelon C, Oravec R, Ramos AB, Niel C, Rossetti ML.
    J Infect; 2005 Jul; 51(1):24-9. PubMed ID: 15979486
    [Abstract] [Full Text] [Related]

  • 44. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M.
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [Abstract] [Full Text] [Related]

  • 45. Occult HBV infection status among chronic hepatitis C and hemodialysis patients in Northeastern Egypt: regional and national overview.
    Mandour M, Nemr N, Shehata A, Kishk R, Badran D, Hawass N.
    Rev Soc Bras Med Trop; 2015 Dec; 48(3):258-64. PubMed ID: 26108002
    [Abstract] [Full Text] [Related]

  • 46. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS.
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [Abstract] [Full Text] [Related]

  • 47. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort.
    Bloquel B, Jeulin H, Burty C, Letranchant L, Rabaud C, Venard V.
    J Med Virol; 2010 Feb; 82(2):206-12. PubMed ID: 20029819
    [Abstract] [Full Text] [Related]

  • 48. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
    Landrum ML, Roediger MP, Fieberg AM, Weintrob AC, Okulicz JF, Crum-Cianflone NF, Ganesan A, Lalani T, Macalino GE, Chun HM.
    J Med Virol; 2011 Sep; 83(9):1537-43. PubMed ID: 21739443
    [Abstract] [Full Text] [Related]

  • 49. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M, Ali R, Khan LA, Husain SA, Singla R, Kar P.
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [Abstract] [Full Text] [Related]

  • 50. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
    Filippini P, Coppola N, Pisapia R, Scolastico C, Marrocco C, Zaccariello A, Nacca C, Sagnelli C, De Stefano G, Ferraro T, De Stefano C, Sagnelli E.
    AIDS; 2006 Jun 12; 20(9):1253-60. PubMed ID: 16816553
    [Abstract] [Full Text] [Related]

  • 51. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.
    Lo Re V, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Localio AR, Kostman JR, Strom BL.
    J Acquir Immune Defic Syndr; 2007 Mar 01; 44(3):315-20. PubMed ID: 17159655
    [Abstract] [Full Text] [Related]

  • 52. Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea.
    Kim SM, Lee KS, Park CJ, Lee JY, Kim KH, Park JY, Lee JH, Kim HY, Yoo JY, Jang MK.
    J Infect; 2007 Feb 01; 54(2):185-91. PubMed ID: 16564573
    [Abstract] [Full Text] [Related]

  • 53. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR.
    Transfus Apher Sci; 2009 Aug 01; 41(1):3-7. PubMed ID: 19487161
    [Abstract] [Full Text] [Related]

  • 54. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
    Tswana S, Chetsanga C, Nyström L, Moyo S, Nzara M, Chieza L.
    S Afr Med J; 1996 Jan 01; 86(1):72-5. PubMed ID: 8685787
    [Abstract] [Full Text] [Related]

  • 55. Prevalence and characteristics of occult hepatitis B virus infection in Japanese human immunodeficiency virus-infected patients.
    Mitsumoto-Kaseida F, Murata M, Takayama K, Toyoda K, Ogawa E, Furusyo N, Hayashi J.
    J Infect Chemother; 2020 Jan 01; 26(1):28-32. PubMed ID: 31279522
    [Abstract] [Full Text] [Related]

  • 56. High prevalence of occult hepatitis B in Baltimore injection drug users.
    Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL.
    Hepatology; 2004 Jan 01; 39(1):51-7. PubMed ID: 14752822
    [Abstract] [Full Text] [Related]

  • 57. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population.
    Fabris P, Baldo V, Baldovin T, Bellotto E, Rassu M, Trivello R, Tramarin A, Tositti G, Floreani A.
    J Clin Gastroenterol; 2008 Jan 01; 42(5):527-32. PubMed ID: 18277889
    [Abstract] [Full Text] [Related]

  • 58. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
    Aydın N, Kırdar S, Uzun N, Eyigör M, Sayan M.
    Mikrobiyol Bul; 2016 Oct 01; 50(4):535-543. PubMed ID: 28124958
    [Abstract] [Full Text] [Related]

  • 59. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO, Tong HV, Bui Tien S, Fagbami AH, Adekanle O, Ojurongbe O, Bock CT, Kremsner PG, Velavan TP.
    PLoS One; 2015 Oct 01; 10(7):e0131912. PubMed ID: 26148052
    [Abstract] [Full Text] [Related]

  • 60. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan 01; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.